Italy ’s Chiesi Farmaceutici to buy Amryt Pharma in a $1.48-billion deal

Italy’s Chiesi Farmaceutici said on Sunday it will acquire Ireland-based drugmaker Amryt Pharma Plc, which has products and drugs in development for treating rare diseases, in a deal valued at $1.48 billion. The total value of the all-cash deal represents a 107 per cent premium over Dublin,…#marcovecchia #ireland #chiesifarmaceutici #myalept #amryt #filsuvez #dublin #amrytpharmaplc #chiesigroup
Source: Reuters: Health - Category: Consumer Health News Source Type: news